AAAAAA

   
Results: 1-10 |
Results: 10
SEQUENTIAL VERSUS SIMULTANEOUS COMBINATION ANTIRETROVIRAL REGIMENS FOR THE TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN-VITRO
Authors: OH MD MERRILL DP SUTTON L HIRSCH MS
Citation: Md. Oh et al., SEQUENTIAL VERSUS SIMULTANEOUS COMBINATION ANTIRETROVIRAL REGIMENS FOR THE TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN-VITRO, The Journal of infectious diseases, 176(2), 1997, pp. 510-514
ANTAGONISM BETWEEN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS INDINAVIR AND SAQUINAVIR IN-VITRO
Authors: MERRILL DP MANION DJ CHOU TC HIRSCH MS
Citation: Dp. Merrill et al., ANTAGONISM BETWEEN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS INDINAVIR AND SAQUINAVIR IN-VITRO, The Journal of infectious diseases, 176(1), 1997, pp. 265-268
NAPHTHALENE SULFONATE POLYMERS WITH CD4-BLOCKING AND ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES
Authors: RUSCONI S MOONIS M MERRILL DP PALLAI PV NEIDHARDT EA SINGH SK WILLIS KJ OSBURNE MS PROFY AT JENSON JC HIRSCH MS
Citation: S. Rusconi et al., NAPHTHALENE SULFONATE POLYMERS WITH CD4-BLOCKING AND ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 234-236
INTRACELLULAR METABOLISM OF ZIDOVUDINE AND STAVUDINE IN COMBINATION -REPLY
Authors: MERRILL DP CHOU TC HIRSCH MS
Citation: Dp. Merrill et al., INTRACELLULAR METABOLISM OF ZIDOVUDINE AND STAVUDINE IN COMBINATION -REPLY, The Journal of infectious diseases, 174(3), 1996, pp. 672-672
LAMIVUDINE OR STAVUDINE IN 2-DRUG AND 3-DRUG COMBINATIONS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN-VITRO
Authors: MERRILL DP MOONIS M CHOU TC HIRSCH MS
Citation: Dp. Merrill et al., LAMIVUDINE OR STAVUDINE IN 2-DRUG AND 3-DRUG COMBINATIONS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN-VITRO, The Journal of infectious diseases, 173(2), 1996, pp. 355-364
EX-VIVO EXPANSION OF CD4 LYMPHOCYTES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS IN THE PRESENCE OF COMBINATION ANTIRETROVIRAL AGENTS
Authors: WILSON CC WONG JT GIRARD DD MERRILL DP DYNAN M AN DD KALAMS SA JOHNSON RP HIRSCH MS DAQUILA RT WALKER BD
Citation: Cc. Wilson et al., EX-VIVO EXPANSION OF CD4 LYMPHOCYTES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS IN THE PRESENCE OF COMBINATION ANTIRETROVIRAL AGENTS, The Journal of infectious diseases, 172(1), 1995, pp. 88-96
INHIBITION OF HIV-1 REPLICATION BY CONVERGENT COMBINATION THERAPY IN MONOCYTE MACROPHAGES/
Authors: RUSCONI S CHOW YK MERRILL DP HIRSCH MS
Citation: S. Rusconi et al., INHIBITION OF HIV-1 REPLICATION BY CONVERGENT COMBINATION THERAPY IN MONOCYTE MACROPHAGES/, AIDS research and human retroviruses, 10, 1994, pp. 190000025-190000025
ALTERNATING VERSUS CONTINUOUS DRUG REGIMENS IN COMBINATION CHEMOTHERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN-VITRO
Authors: MAZZULI T RUSCONI S MERRILL DP DAQUILA RT MOONIS M CHOU TC HIRSCH MS
Citation: T. Mazzuli et al., ALTERNATING VERSUS CONTINUOUS DRUG REGIMENS IN COMBINATION CHEMOTHERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN-VITRO, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 656-661
INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN CYTOKINE-STIMULATED MONOCYTES MACROPHAGES BY COMBINATION THERAPY
Authors: RUSCONI S MERRILL DP HIRSCH MS
Citation: S. Rusconi et al., INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN CYTOKINE-STIMULATED MONOCYTES MACROPHAGES BY COMBINATION THERAPY, The Journal of infectious diseases, 170(6), 1994, pp. 1361-1366
USE OF EVOLUTIONARY LIMITATIONS OF HIV-1 MULTIDRUG-RESISTANCE TO OPTIMIZE THERAPY (VOL 361, PG 650, 1993)
Authors: CHOW YK HIRSCH MS MERRILL DP BECHTEL LJ ERON JJ KAPLAN JC DAQUILA RT
Citation: Yk. Chow et al., USE OF EVOLUTIONARY LIMITATIONS OF HIV-1 MULTIDRUG-RESISTANCE TO OPTIMIZE THERAPY (VOL 361, PG 650, 1993), Nature, 364(6439), 1993, pp. 737-737
Risultati: 1-10 |